At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 124 enrolled
Drug / intervention
CSTC1 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized,Double-Blind,Vehicle-controlled,Parallel,Phase II Study to Evaluate Efficacy and Safety of CSTC1 in Patient With Diabetic Foot Ulcers
In Brief
A Phase 2 clinical trial evaluating CSTC1 and CSTC1 Matched vehicle for Diabetic Foot Ulcer and 2 related conditions. Completed, enrolled 124 participants across 1 site.
Detailed Summary
The objective of this study is to evaluate the efficacy and safety of CSTC1 in patient with diabetic foot ulcers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Foot Ulcer, Diabetes Mellitus, Wounds
CountriesTaiwan
CollaboratorsASKLEP Inc.
Timeline
Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMar 2013
Enrollment StartJul 2014
Primary CompletionJan 2020
TodayJul 2026
First PostedMar 18, 2013
Enrollment StartJul 9, 2014
Primary CompletionJan 7, 2020
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 13.3 years ago
Interventions
CSTC1drug
vapor fraction from seeds of Glycine max (L.) Merr. and composition thereof
CSTC1 Matched vehicledrug